Michael Skinner
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Treatment of Major Depression
- Antibiotics Pharmacokinetics and Efficacy
- Physiology top 10%
- Alzheimer's disease research and treatments
Papers in
-
- Pharmacogenetics and Drug Metabolism 7
- Inflammatory mediators and NSAID effects 1
-
- Poisoning and overdose treatments 2
- Co-authors
- Terrence F. Blaschke (6 shared papers)Mary Pat Knadler (6 shared papers)Celedon Gonzales (5 shared papers)Shobha R. Reddy (4 shared papers)Julie H. Satterwhite (2 shared papers)Patrick C. May (2 shared papers)Eric Siemers (2 shared papers)Todd A. Gillespie (1 shared paper)
- Journals
- Clinical Pharmacokinetics (2 papers)Clinical Pharmacology & Therapeutics (2 papers)British Journal of Clinical Pharmacology (2 papers)Journal of Clinical Investigation (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesSingaporeGermany
In The Last Decade
Michael Skinner
24 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 84
- Pharmacology 265
- Pharmacology 188
- Physiology 214
- Toxicology 38
- Infectious Diseases 115
Countries citing papers authored by Michael Skinner
This map shows the geographic impact of Michael Skinner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Skinner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Skinner more than expected).
Fields of papers citing papers by Michael Skinner
This network shows the impact of papers produced by Michael Skinner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Skinner. The network helps show where Michael Skinner may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Skinner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 186 | |
| 2 | 2003 | 178 | |
| 3 | 2003 | 162 | |
| 4 | 1996 | 124 | |
| 5 | 2002 | 118 | |
| 6 | 1995 | 73 | |
| 7 | 1989 | 72 | |
| 8 | 2003 | 62 | |
| 9 | 2023 | 48 | |
| 10 | 1992 | 44 | |
| 11 | 2005 | 42 | |
| 12 | 2010 | 38 | |
| 13 | 2004 | 24 | |
| 14 | 1990 | 21 | |
| 15 | 1989 | 17 | |
| 16 | 1993 | 17 | |
| 17 | 1996 | 16 | |
| 18 | 1996 | 14 | |
| 19 | 2004 | 14 | |
| 20 | Acetaminophen metabolism in recovering alcoholics. | 1990 | 10 |
About Michael Skinner
Michael Skinner is a scholar working on Pharmacology, Emergency Medicine, Epidemiology, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 25 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Blood Pressure and Hypertension Studies (3 papers), Substance Abuse Treatment and Outcomes (3 papers), Poisoning and overdose treatments (2 papers), Alzheimer's disease research and treatments (2 papers), HIV/AIDS drug development and treatment (2 papers), Analytical Methods in Pharmaceuticals (1 paper) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Pharmacology (265 citations), Pharmacology (188 citations), Physiology (214 citations), Toxicology (38 citations) and Infectious Diseases (115 citations). Michael Skinner has collaborated with scholars based in United States, Singapore and Germany. Frequent co-authors include Terrence F. Blaschke, Mary Pat Knadler, Celedon Gonzales, Shobha R. Reddy, Julie H. Satterwhite, Patrick C. May, Eric Siemers, Todd A. Gillespie, Robert A. Dean and Martin Rhys Farlow. Their work appears in journals such as Clinical Pharmacokinetics, Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology, Journal of Clinical Investigation and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.